A detailed history of Trinity Point Wealth, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Trinity Point Wealth, LLC holds 23,310 shares of ABT stock, worth $2.62 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
23,310
Previous 21,906 6.41%
Holding current value
$2.62 Million
Previous $2.49 Million 2.69%
% of portfolio
0.39%
Previous 0.42%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$100.73 - $112.44 $141,424 - $157,865
1,404 Added 6.41%
23,310 $2.42 Million
Q1 2024

May 08, 2024

BUY
$109.52 - $120.96 $72,173 - $79,712
659 Added 3.1%
21,906 $2.49 Million
Q4 2023

Feb 08, 2024

BUY
$90.19 - $110.4 $33,911 - $41,510
376 Added 1.8%
21,247 $2.34 Million
Q3 2023

Nov 08, 2023

BUY
$95.53 - $114.62 $30,283 - $36,334
317 Added 1.54%
20,871 $2.02 Million
Q2 2023

Aug 07, 2023

BUY
$100.78 - $112.29 $141,192 - $157,318
1,401 Added 7.31%
20,554 $2.24 Million
Q1 2023

May 04, 2023

BUY
$96.86 - $114.01 $27,605 - $32,492
285 Added 1.51%
19,153 $1.94 Million
Q4 2022

Feb 07, 2023

BUY
$95.06 - $111.52 $100,193 - $117,542
1,054 Added 5.92%
18,868 $2.07 Million
Q3 2022

Nov 09, 2022

BUY
$96.76 - $112.03 $55,540 - $64,305
574 Added 3.33%
17,814 $1.72 Million
Q2 2022

Aug 05, 2022

SELL
$102.07 - $123.37 $4,389 - $5,304
-43 Reduced 0.25%
17,240 $1.87 Million
Q1 2022

May 13, 2022

BUY
$114.02 - $139.04 $4,674 - $5,700
41 Added 0.24%
17,283 $2.05 Million
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $12,939 - $15,843
112 Added 0.65%
17,242 $2.43 Million
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $1,283 - $1,419
-11 Reduced 0.06%
17,130 $2.02 Million
Q2 2021

Aug 13, 2021

BUY
$105.79 - $124.53 $17,772 - $20,921
168 Added 0.99%
17,141 $1.99 Million
Q1 2021

May 11, 2021

SELL
$108.84 - $128.23 $26,339 - $31,031
-242 Reduced 1.41%
16,973 $2.03 Million
Q4 2020

Feb 10, 2021

BUY
$105.0 - $114.42 $222,390 - $242,341
2,118 Added 14.03%
17,215 $1.98 Million
Q3 2020

Nov 13, 2020

SELL
$91.64 - $111.29 $57,458 - $69,778
-627 Reduced 3.99%
15,097 $1.64 Million
Q2 2020

Aug 13, 2020

SELL
$76.57 - $98.0 $47,856 - $61,250
-625 Reduced 3.82%
15,724 $1.44 Million
Q1 2020

May 05, 2020

SELL
$62.82 - $91.86 $43,345 - $63,383
-690 Reduced 4.05%
16,349 $1.29 Million
Q4 2019

Feb 06, 2020

SELL
$78.51 - $87.4 $117,372 - $130,663
-1,495 Reduced 8.07%
17,039 $1.48 Million
Q3 2019

Nov 07, 2019

BUY
$81.84 - $88.74 $867,176 - $940,289
10,596 Added 133.48%
18,534 $1.52 Million
Q2 2019

Aug 06, 2019

SELL
$72.88 - $85.0 $72,515 - $84,575
-995 Reduced 11.14%
7,938 $703,000
Q1 2019

May 07, 2019

BUY
$66.22 - $80.06 $338,847 - $409,667
5,117 Added 134.09%
8,933 $714,000
Q4 2018

Feb 11, 2019

BUY
$65.56 - $74.27 $250,176 - $283,414
3,816 New
3,816 $276,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Trinity Point Wealth, LLC Portfolio

Follow Trinity Point Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trinity Point Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trinity Point Wealth, LLC with notifications on news.